The 3-day course is a shortened version of the course which has been given for the last eight years by Prof Bernd Meibohm & Johan Gabrielsson in the United States, and it is organized in Europe for the third time under the aegis of AP2POP association.
During this course, you will be introduced to basic principles in the pharmacokinetic and pharmacodynamic evaluation of novel therapeutic proteins and hands-on exercises in the PK/PD evaluation of these compounds. Topics include target-mediated drug disposition, tissue and tumor penetration, first-in-human dose selection, immunogenicity, clinical pharmacology challenges, biosimilars, and drug-drug interactions. The target audience comprises pharmaceutical scientists from industry, academia and regulatory agencies with basic knowledge in PK and PKPD that would like to receive a comprehensive overview or refresher on the PK and PKPD of this class of compounds. Hands-on exercises will be performed individually and in small groups using simple software tools (no prior experience required).
Attendance and registration:
The attendance will be strictly limited to 35 participants, allowing nice interactions. As well, a limited number of spots have been reserved for academia and trainees for one third of the price.
For more detailed information on the preliminary course program, as well as on the registration process, please visit:
Information: http://www.ap2pop.org/formations
Registration form: http://www.ap2pop.org/assets/PDF/Plaquette-formation-AP2POP-2018-PKPDofPT.pdf
Looking forward to seeing you in Lyon!
The Course Directors
Bernd Meibohm, University of Tennessee & Johan Gabrielsson, Swedish University of Agricultural Sciences
The Local Organizers
Emilie Hénin and Christian Laveille, Calvagone & AP2POP
AP2POP, Association pour la Promotion de la Pharmacocinétique de Population
